Skip to main content

Table 2 Association of IVIG treatment with mortality

From: Clinical outcomes of intravenous immunoglobulin therapy in COVID-19 related acute respiratory distress syndrome: a retrospective cohort study

 

Total (n)

sHR (95% confidence interval)

P value

PS matched analysis

236

3.50 (1.98–6.19)

 < 0.001

PS adjusted analysis

556*

2.98 (1.92–4.60)

 < 0.001

  1. IVIG, intravenous immunoglobulin; PS, propensity score; sHR, sub-distribution hazard ratio
  2. *Propensity score could not be calculated for 34 patients due to complete separation by baseline characteristics
Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us